Infasurf Related Published Studies
Well-designed clinical trials related to Infasurf (Calfactant)
Post hoc analysis of calfactant use in immunocompromised children with acute lung injury: Impact and feasibility of further clinical trials. [2008.08.01]
A critical appraisal of a randomized controlled trial: Willson et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476). [2007.01]
A critical appraisal of a randomized controlled trial: Willson et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury (JAMA 2005, 293: 470-476). [2006.12.04]
Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. [2005.08]
Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. [2005.01.26]
Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Members of the Mid-Atlantic Pediatric Critical Care Network. [1999.01]
Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. [1997.07]
Well-designed clinical trials possibly related to Infasurf (Calfactant)
Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure. [2005.03]
Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial. [2004.10]
High-versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. [2000.08]
Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. [1998.06]
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. [1997.07]
A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. [1996.03]
Other research related to Infasurf (Calfactant)
Post hoc analysis of calfactant use in immunocompromised children with acute lung injury: Impact and feasibility of further clinical trials. [2008.09]
Comparison of beractant and calfactant in a neonatal intensive care unit. [2004.02.01]
Calfactant sterility in multiple doses from single-use vials. [2003.09]
Calfactant. [2001.09]
Calfactant: a review of its use in neonatal respiratory distress syndrome. [1999.07]
Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria. [1992.09]
Other possibly related research studies
Lavage administration of dilute surfactant in a piglet model of meconium aspiration. [2004]
[The impact of mechanical ventilation strategies that minimize atelectrauma in an experimental model of acute lung injury] [2004.05]
Surfactant therapy for acute lung injury/acute respiratory distress syndrome. [2004.02]
Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. [2004.06]
Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury. [2004]
Longitudinal, 15-year follow-up of children born at less than 29 weeks' gestation after introduction of surfactant therapy into a region: neurologic, cognitive, and educational outcomes. [2002.12]
Mechanisms of surface-tension-induced epithelial cell damage in a model of pulmonary airway reopening. [2003.02]
A comparison of the outcomes of neonates treated with two different natural surfactants. [2001.12]
High-frequency oscillatory ventilation and partial liquid ventilation after acute lung injury in premature lambs with respiratory distress syndrome. [2000.07]
Increased survival in low birth weight neonates given prophylactic surfactant. [1998.11]
Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury. [1998.09]
Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. [1998.07]
Lavage administration of dilute surfactants after acute lung injury in neonatal piglets. [1998.07]
Tracheal ligation: the dark side of in utero congenital diaphragmatic hernia treatment. [1997.03]
Quantitation of the alveolar distribution of surfactant mixtures in normal and injured lungs. [1996.10]
Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs. [1996.06]
Natural vs synthetic surfactants in neonatal respiratory distress syndrome. [1996.02]
Controversies: synthetic or natural surfactant. The case for natural surfactant. [1996]
Comparison of exogenous surfactants in the treatment of wood smoke inhalation. [1995.08]
Surfactant protein-B supplementation improves in vivo function of a modified natural surfactant. [1995.03]
Pre- versus post-ventilatory surfactant treatment in surfactant-deficient preterm lambs. [1995]
Pathophysiology of congenital diaphragmatic hernia. VIII: Inhaled nitric oxide requires exogenous surfactant therapy in the lamb model of congenital diaphragmatic hernia. [1995.01]
Overview of clinical trials comparing natural and synthetic surfactants. [1995]
A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs. [1992.05]
Calf lung surfactant extract prophylaxis and retinopathy of prematurity. [1992.04]
Prenatal glucocorticoids and exogenous surfactant therapy improve respiratory function in lambs with severe diaphragmatic hernia following fetal tracheal occlusion. [2006.08]
Restoration of mucociliary transport in the fluid-depleted trachea by surface-active instillates. [2006.04]
Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH. [1992.07]
Lung surfactants. [2006.08.15]
Animal-derived surfactants versus past and current synthetic surfactants: current status. [2007.03]
False-positive results on colorimetric carbon dioxide analysis in neonatal resuscitation: potential for serious patient harm. [2007.12]
Choosing a Right Surfactant for Respiratory Distress Syndrome Treatment. [2008.10.02]
|
